Page 2 - Andreas Bergmann News Today

DGAP-News: SphingoTec GmbH / Key word(s): Scientific publication/Study results The Biomarkers bio-ADM and DPP3 Complement Post-Cardiac Surgery Diagnostics to Early Detect Organ Failure 24.03.2022

15.03.2022 Proenkephalin (penKid) sheds light on the diagnostic blind spots in assessing acute kidney injury in children | acute kidney injury | AKI | biomarker

SphingoTec Appoints Jörg Menten to Leadership Team as Chief Commercial Officer to Drive New Business Growth - read this article along with other careers information, tips and advice on BioSpace

Investegate announcements from AGC Biologics, 4TEEN4 Pharmaceuticals Selects AGC Biologics to Manufacture Procizumab

4TEEN4 Pharmaceuticals Selects AGC Biologics to Manufacture Procizumab AGC Biologics to produce Procizumab for early and late clinical phases at company’s Chiba and Copenhagen facilities GlobeNewswire December 01, 2021 Seattle, Dec. 01, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new...

This South Florida city's startup scene is looking sunny.

Diskussion Die New O’Lienz Jazztage laden alljährlich zu Konzerten in das einmalige Ambiente des Eisenbahnmuseums im Heizhaus Lienz. © Brunner Images Von Christoph Blassnig Lienz – Zwischen den historischen Schienenfahrzeugen riecht es nach Öl, die Akustik im Heizhaus Lienz ist dank der riesigen verrußten Oberflächen im denkmalgeschützten Dachstuhl trocken und klar. „Das Ambiente ist einmalig und genau das, was wir für unsere Konzerte gesucht haben“, erklärt Andreas Bergmann, ...

DGAP-News: SphingoTec GmbH / Key word(s): Corporate Action/Strategic Company Decision SphingoTec Expands Management Team and Appoints new CFO 10.06.2021 / 10:00 The issuer is solely responsible for the content of this announcement. Dr. Angelo Moesslang was named CFO and Managing Director of Sphi...

DGAP-News: SphingoTec Accelerates Growth with Direct Sales vom 20.05.2021, 10:00 Uhr Bild: pixabay.com SphingoTec Accelerates Growth with Direct Sales 20.05.2021 / 10:00 The issuer is solely responsible for the content of this announcement. SphingoTec to expand the commercialization strategy by establishing a sales division and appointing new head of sales Tailored diagnostic solutions for point of care use Innovative proprietary biomarkers and standard parameters available on the fully auto...

DGAP-News: SphingoTec GmbH / Key word(s): Corporate Action/Strategic Company Decision SphingoTec Accelerates Growth with Direct Sales 20.05.2021 / 10:00 The issuer is solely responsible